Olmesartan Medoxomil And Hydrochlorothiazide Tablet
Product Images NDC 50090-5450

3 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 50090-5450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905450)

Label Image (Lbl500905450)
Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide tablets, 40 mg/25 mg strength, manufactured by A-S Medication Solutions. The label indicates 90 tablets in the package and includes storage instructions to keep at 60 to 77 degrees Fahrenheit. The label also features the product NDC as 50090-5450 and specifies oral administration.*
FDA Label Image

Olme-hctz-structure-1 (Olme Hctz Structure 1)

Olme-hctz-structure-1 (Olme Hctz Structure 1)
Chemical structure of Olmesartan Medoxomil, the active ingredient in Olmesartan Medoxomil and Hydrochlorothiazide tablets, is shown. The diagram displays its molecular configuration with rings and side chains characteristic of the compound.*
FDA Label Image

Olme-hctz-structure-2 (Olme Hctz Structure 2)

Olme-hctz-structure-2 (Olme Hctz Structure 2)
Chemical structure of Olmesartan Medoxomil and Hydrochlorothiazide active ingredient, displaying the molecular arrangement as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.